Riggs Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $258K | Sell |
1,026
-10
| -1% | -$2.15K | 0.05% | 116 |
|
|
2026
Q1 | $225K | Hold |
1,036
| – | – | 0.05% | 122 |
|
|
2025
Q4 | $237K | Buy |
+1,036
| New | +$236K | 0.05% | 121 |
|
|
2025
Q3 | – | Sell |
-204
| Closed | -$37.9K | – | 118 |
|
|
2025
Q2 | $37.9K | Buy |
204
+8
| +4% | +$1.49K | 0.01% | 192 |
|
|
2025
Q1 | $41.1K | Buy |
196
+2
| +1% | +$389 | 0.01% | 169 |
|
|
2024
Q4 | $34.2K | Hold |
194
| – | – | 0.01% | 170 |
|
|
2024
Q3 | $38.3K | Buy |
194
+10
| +5% | +$1.87K | 0.01% | 165 |
|
|
2024
Q2 | $31.6K | Sell |
184
-59
| -24% | -$9.77K | 0.01% | 164 |
|
|
2024
Q1 | $44.3K | Buy |
243
+7
| +3% | +$1.21K | 0.01% | 144 |
|
|
2023
Q4 | $36.6K | Hold |
236
| – | – | 0.01% | 151 |
|
|
2023
Q3 | $35.2K | Hold |
236
| – | – | 0.01% | 157 |
|
|
2023
Q2 | $31.8K | Sell |
236
-33,239
| -99% | -$4.87M | 0.01% | 163 |
|
|
2023
Q1 | $5.33M | Sell |
33,475
-1,311
| -4% | -$200K | 2.07% | 13 |
|
|
2022
Q4 | $5.62M | Buy |
34,786
+813
| +2% | +$125K | 2.32% | 10 |
|
|
2022
Q3 | $4.56M | Buy |
33,973
+528
| +2% | +$75.8K | 1.81% | 21 |
|
|
2022
Q2 | $5.12M | Sell |
33,445
-16,856
| -34% | -$2.58M | 2.11% | 17 |
|
|
2022
Q1 | $8.15M | Sell |
50,301
-9,326
| -16% | -$1.35M | 2.39% | 10 |
|
|
2021
Q4 | $8.07M | Buy |
59,627
+158
| +0.3% | +$18.7K | 2.19% | 13 |
|
|
2021
Q3 | $6.42M | Sell |
59,469
-3,113
| -5% | -$356K | 1.93% | 16 |
|
|
2021
Q2 | $7.05M | Buy |
62,582
+3,039
| +5% | +$342K | 1.96% | 14 |
|
|
2021
Q1 | $6.44M | Sell |
59,543
-740
| -1% | -$79.2K | 1.95% | 16 |
|
|
2020
Q4 | $6.46M | Buy |
60,283
+22,619
| +60% | +$2.17M | 1.98% | 21 |
|
|
2020
Q3 | $3.3M | Buy |
37,664
+148
| +0.4% | +$13.9K | 1.39% | 25 |
|
|
2020
Q2 | $3.68M | Buy |
37,516
+36,670
| +4,335% | +$3.23M | 1.49% | 28 |
|
|
2020
Q1 | $64K | Hold |
846
| – | – | 0.04% | 88 |
|
|
2019
Q4 | $75K | Hold |
846
| – | – | 0.03% | 105 |
|
|
2019
Q3 | $64K | Hold |
846
| – | – | 0.03% | 104 |
|
|
2019
Q2 | $62K | Hold |
846
| – | – | 0.03% | 106 |
|
|
2019
Q1 | $68K | Buy |
846
+800
| +1,739% | +$65.4K | 0.05% | 98 |
|
|
2018
Q4 | $4K | Hold |
46
| – | – | ﹤0.01% | 186 |
|
|
2018
Q3 | $4K | Hold |
46
| – | – | ﹤0.01% | 199 |
|
|
2018
Q2 | $4K | Hold |
46
| – | – | ﹤0.01% | 212 |
|
|
2018
Q1 | $4K | Hold |
46
| – | – | ﹤0.01% | 232 |
|
|
2017
Q4 | $4K | Hold |
46
| – | – | ﹤0.01% | 230 |
|
|
2017
Q3 | $4K | Hold |
46
| – | – | ﹤0.01% | 225 |
|
|
2017
Q2 | $3K | Hold |
46
| – | – | ﹤0.01% | 252 |
|
|
2017
Q1 | $3K | Sell |
46
-81,885
| -100% | -$5.15M | ﹤0.01% | 233 |
|
|
2016
Q4 | $5.13M | Buy |
81,931
+1,947
| +2% | +$119K | 2.55% | 17 |
|
|
2016
Q3 | $5.04M | Sell |
79,984
-364
| -0.5% | -$23.6K | 2.62% | 19 |
|
|
2016
Q2 | $4.97M | Buy |
80,348
+51,619
| +180% | +$3.15M | 2.61% | 19 |
|
|
2016
Q1 | $1.64M | Buy |
28,729
+27,733
| +2,784% | +$1.55M | 1.18% | 22 |
|
|
2015
Q4 | $59K | Hold |
996
| – | – | 0.03% | 97 |
|
|
2015
Q3 | $54K | Buy |
996
+400
| +67% | +$26K | 0.03% | 88 |
|
|
2015
Q2 | $40K | Buy |
596
+183
| +44% | +$11.9K | 0.02% | 121 |
|
|
2015
Q1 | $24K | Hold |
413
| – | – | 0.01% | 150 |
|
|
2014
Q4 | $27K | Hold |
413
| – | – | 0.01% | 150 |
|
|
2014
Q3 | $24K | Buy |
+413
| New | +$22.9K | 0.01% | 149 |
|
Other funds holding ABBV
Riggs Asset Management's ABBV Position: Q2 2026 in Review
Riggs Asset Management reduced its AbbVie (ABBV) stake by 0.97% in Q2 2026, selling an estimated $2.15K and leaving 1,026 shares worth $258K. The position accounts for 0.05% of the portfolio, ranked #116.
Riggs Asset Management first reported a position in ABBV in Q3 2014 and has held it in 47 quarters since. The position peaked at $8.15M in Q1 2022. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Riggs Asset Management held 1,026 shares of AbbVie worth $258K as of Q2 2026.
- Riggs Asset Management sold 10 AbbVie shares in Q2 2026, an estimated $2.15K.
- AbbVie made up 0.05% of Riggs Asset Management's portfolio in Q2 2026, its #116 holding.
- Riggs Asset Management first reported a position in AbbVie in Q3 2014 and has held it in 47 quarters since.
- Riggs Asset Management's AbbVie position peaked at $8.15M in Q1 2022.
- 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Riggs Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.